Altamira Therapeutics Ltd.

Historical 13F Holders

Symbol
CYTOF
CUSIP
G0360L134
All holders as of
Q2 2026
Type
Equity
Class
SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G0360L134 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 2
4.99% 11/14/2025
Event 9/30/2025
Armistice Capital, LLC 13G/A Amendment 1
10.0% 8/14/2025
Event 6/30/2025
Armistice Capital, LLC 13G/A Amendment 2
10.0% 5/15/2025
Event 3/31/2025
Thomas Meyer 13D/A Amendment 14 18.9% 5/6/2025
Event 4/30/2025
Armistice Capital, LLC 13G/A Amendment 1
10.0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 1 1.00 $0
2026 Q1 1 1.00 $0
2025 Q4 1 1.00 $0
2025 Q3 1 1.00 $0
2025 Q2 1 1.00 $0
2025 Q1 1 1.00 $0
2024 Q4 2 10.9 k $1.21 k
2024 Q3 6 116 k $71.3 k
2024 Q2 6 3.59 k $3.99 k
2024 Q1 4 1.68 k $3.47 k
2023 Q4 5 7.68 k $26.7 k